news Protease inhibitor aprotinin shows promise against SARS-CoV-2 in cells 5 November 2020 | By Victoria Rees (Drug Target Review) Researchers have found that aprotinin, an approved drug for influenza in Russia, combats SARS-CoV-2 in cells.